| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |